Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Ralph Laufer"'
Autor:
Marianna Bugiani, Truus E. M. Abbink, Arthur W. D. Edridge, Lia van derHoek, Anne E. J. Hillen, Niek P. vanTil, Gino V. Hu‐A‐Ng, Marjolein Breur, Karen Aiach, Philippe Drevot, Michaël Hocquemiller, Ralph Laufer, Frits A. Wijburg, Marjo S. van derKnaap
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 6, Pp 904-917 (2023)
Abstract Objective Mucopolysaccharidosis type IIIA (MPSIIIA) caused by recessive SGSH variants results in sulfamidase deficiency, leading to neurocognitive decline and death. No disease‐modifying therapy is available. The AAVance gene therapy trial
Externí odkaz:
https://doaj.org/article/7b120ba2fed845d38eb844ce2a9e52f1
Autor:
Michaël Hocquemiller, Laura Giersch, Xin Mei, Amanda L. Gross, Ashley N. Randle, Heather L. Gray-Edwards, Judith A. Hudson, Sophia Todeasa, Lorelei Stoica, Douglas R. Martin, Miguel Sena-Esteves, Karen Aiach, Ralph Laufer
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 27, Iss , Pp 281-292 (2022)
GM1 gangliosidosis is a rare, inherited neurodegenerative disorder caused by mutations in the GLB1 gene, which encodes the lysosomal hydrolase acid β-galactosidase (β-gal). β-gal deficiency leads to toxic accumulation of GM1 ganglioside, predomina
Externí odkaz:
https://doaj.org/article/157bca7427c44bc4a59c76e532caa74e
AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model
Autor:
Karima Habbas, Oktay Cakil, Boglárka Zámbó, Ricardos Tabet, Fabrice Riet, Doulaye Dembele, Jean‐Louis Mandel, Michaël Hocquemiller, Ralph Laufer, Françoise Piguet, Hervé Moine
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 5, Pp 1-15 (2022)
Abstract Fragile X syndrome (FXS) is the most frequent form of familial intellectual disability. FXS results from the lack of the RNA‐binding protein FMRP and is associated with the deregulation of signaling pathways downstream of mGluRI receptors
Externí odkaz:
https://doaj.org/article/f6fe6fea1bab4023b24b4f87b67b8131
Autor:
Michaël Hocquemiller, Kim M. Hemsley, Meghan L. Douglass, Sarah J. Tamang, Daniel Neumann, Barbara M. King, Helen Beard, Paul J. Trim, Leanne K. Winner, Adeline A. Lau, Marten F. Snel, Cathy Gomila, Jérôme Ausseil, Xin Mei, Laura Giersch, Mark Plavsic, Ralph Laufer
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 174-187 (2020)
Patients with mucopolysaccharidosis type IIIA (MPS IIIA) lack the lysosomal enzyme sulfamidase (SGSH), which is responsible for the degradation of heparan sulfate (HS). Build-up of undegraded HS results in severe progressive neurodegeneration for whi
Externí odkaz:
https://doaj.org/article/dc201b70e27746bcae02d970deb12fca
Autor:
Maria Rosaria Battista, Antonella Grigoletto, Tommaso Tedeschini, Antonella Cellucci, Fabrizio Colaceci, Ralph Laufer, Gianfranco Pasut, Annalise Di Marco
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Ciliary neurotrophic factor (CNTF) is a neurotrophic cytokine able to induce appetite reduction, weight loss and antidiabetic effects. However, its susceptibility to neutralizing anti-CNTF antibodies in patients hampered its use for treatment of huma
Externí odkaz:
https://doaj.org/article/275712289d7d46749feca52a20c48f5e
Autor:
Sarka Pokorna, Olga Khersonsky, Rosalie Lipsh‐Sokolik, Adi Goldenzweig, Rebekka Nielsen, Yacov Ashani, Yoav Peleg, Tamar Unger, Shira Albeck, Orly Dym, Asa Tirosh, Rana Tarayra, Michaël Hocquemiller, Ralph Laufer, Shifra Ben‐Dor, Israel Silman, Joel L. Sussman, Sarel J. Fleishman, Anthony H. Futerman
Publikováno v:
The FEBS Journal.
Autor:
Lysogene
Publikováno v:
Business Wire (English). 05/15/2018.
Autor:
Adeline A. Lau, Mark Plavsic, Marten F. Snel, Leanne K. Winner, Barbara King, Meghan L. Douglass, Xin Mei, Michaël Hocquemiller, Laura Giersch, Ralph Laufer, Paul J. Trim, Jérôme Ausseil, Helen Beard, Cathy Gomila, Daniel Neumann, Kim M. Hemsley, Sarah J. Tamang
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 174-187 (2020)
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 174-187 (2020)
Patients with mucopolysaccharidosis type IIIA (MPS IIIA) lack the lysosomal enzyme sulfamidase (SGSH), which is responsible for the degradation of heparan sulfate (HS). Build-up of undegraded HS results in severe progressive neurodegeneration for whi
Autor:
Maria Rosaria Battista, Antonella Grigoletto, Tommaso Tedeschini, Antonella Cellucci, Fabrizio Colaceci, Ralph Laufer, Gianfranco Pasut, Annalise Di Marco
Publikováno v:
PloS one. 17(3)
Ciliary neurotrophic factor (CNTF) is a neurotrophic cytokine able to induce appetite reduction, weight loss and antidiabetic effects. However, its susceptibility to neutralizing anti-CNTF antibodies in patients hampered its use for treatment of huma